查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1302509

连续肾臟替代治疗市场：按产品、疗法、方式和最终用户 - 全球预测 2023-2030

Continuous Renal Replacement Therapy Market by Product, Therapy, Modality, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到2023年，全球持续肾臟替代治疗市场规模将达到185亿美元，年复合成长率为8.53%，预计将在2030年达到328.8亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球连续性肾臟替代治疗市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.持续性肾臟替代治疗的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球连续性肾臟替代治疗市场的抑制要素和影响有哪些？

3.在预测期内，全球连续性肾臟替代治疗市场需要投资哪些产品/细分市场/应用/领域？

4、全球连续性肾臟替代治疗市场的竞争策略是什么？

5. 全球连续性肾臟替代治疗市场的技术趋势和法律规范是什么？

6.全球连续性肾臟替代治疗市场主要供应商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入全球连续性肾臟替代治疗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 急性肾损伤（AKI）发生率增加
      • 体外治疗技术的进步
      • CRRT 间歇性血液净化的临床效益猛增
    • 抑制因素
      • 连续肾臟替代治疗程序需要高昂的费用
    • 机会
      • 持续研发以提高 CRRT 的安全性和有效性
      • 儿科患者 CCRT 系统的开发
    • 课题
      • 与连续肾臟替代治疗相关的技术问题
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户定制

第6章连续肾臟替代治疗市场：副产品

  • 谱系集
  • 透析液和置换液
  • 一次性用品
  • 血液过滤器
  • 系统

第7章按治疗方法分類的连续肾臟替代治疗市场

  • 非肾性的
  • 肾

第8章按方式分類的连续肾臟替代治疗市场

  • 连续性静脉-静脉血液透析滤过
  • 连续性静脉-静脉血液透析
  • 连续静脉静脉血液滤过
  • 低速连续超过滤

第9章连续肾臟替代治疗市场：按最终用户分类

  • 透析诊所
  • 住宅
  • 医院

第10章美洲连续肾臟替代治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太地区持续肾臟替代治疗市场

  • 澳大利亚
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲连续肾臟替代治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 意大利
  • 荷兰
  • 尼日利亚
  • 挪威
  • 波兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯联合酋长国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市场份额分析：主要企业
  • 竞争情景分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可和定价
Product Code: MRR-433AB1DC293B

The Global Continuous Renal Replacement Therapy Market is forecasted to grow significantly, with a projected USD 18.50 billion in 2023 at a CAGR of 8.53% and expected to reach a staggering USD 32.88 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Renal Replacement Therapy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Renal Replacement Therapy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Bloodline Sets, Dialysates & Replacement Fluids, Disposables, Hemofilters, and Systems. The Systems is projected to witness significant market share during forecast period.

Based on Therapy, market is studied across Non-renal and Renal. The Non-renal is projected to witness significant market share during forecast period.

Based on Modality, market is studied across Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemofiltration, and Slow Continuous Ultrafiltration. The Slow Continuous Ultrafiltration is projected to witness significant market share during forecast period.

Based on End User, market is studied across Dialysis Clinics, Homes, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Renal Replacement Therapy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Renal Replacement Therapy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Renal Replacement Therapy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Renal Replacement Therapy Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Renal Replacement Therapy Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Renal Replacement Therapy Market?

6. What is the market share of the leading vendors in the Global Continuous Renal Replacement Therapy Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Renal Replacement Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Continuous Renal Replacement Therapy Market, by Product, 2022 vs 2030
  • 4.3. Continuous Renal Replacement Therapy Market, by Therapy, 2022 vs 2030
  • 4.4. Continuous Renal Replacement Therapy Market, by Modality, 2022 vs 2030
  • 4.5. Continuous Renal Replacement Therapy Market, by End User, 2022 vs 2030
  • 4.6. Continuous Renal Replacement Therapy Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute kidney injury (AKI)
      • 5.1.1.2. Increasing technological advancement in the extracorporeal therapies
      • 5.1.1.3. Surging clinical advantages of CRRT over intermittent blood purification
    • 5.1.2. Restraints
      • 5.1.2.1. Need for massive cost for continuous renal replacement therapy procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
      • 5.1.3.2. Developments of CCRT systems for pediatric patients
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications associated with continuous renal replacement therapy
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Continuous Renal Replacement Therapy Market, by Product

  • 6.1. Introduction
  • 6.2. Bloodline Sets
  • 6.3. Dialysates & Replacement Fluids
  • 6.4. Disposables
  • 6.5. Hemofilters
  • 6.6. Systems

7. Continuous Renal Replacement Therapy Market, by Therapy

  • 7.1. Introduction
  • 7.2. Non-renal
  • 7.3. Renal

8. Continuous Renal Replacement Therapy Market, by Modality

  • 8.1. Introduction
  • 8.2. Continuous Venovenous Hemodiafiltration
  • 8.3. Continuous Venovenous Hemodialysis
  • 8.4. Continuous Venovenous Hemofiltration
  • 8.5. Slow Continuous Ultrafiltration

9. Continuous Renal Replacement Therapy Market, by End User

  • 9.1. Introduction
  • 9.2. Dialysis Clinics
  • 9.3. Homes
  • 9.4. Hospitals

10. Americas Continuous Renal Replacement Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2022 VS 2030 (%)
  • FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2030 (%)
  • FIGURE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
  • FIGURE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY BLOODLINE SETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSATES & REPLACEMENT FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NON-RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 14. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SLOW CONTINUOUS ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 191. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 192. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET LICENSE & PRICING